On the right, you’ll find our best CADTH evidence on medical cannabis.

You might also want to browse CADTH’s evidence bundle on mental health.

Under “Additional Resources,” you’ll find additional non-CADTH evidence is available from Canadian Government and Association Resources, Journal Articles, and Policy Statements and Guidance. A literature search for key resources was conducted, including The Cochrane Library, The National Guideline Clearinghouse, both Canadian and international health technology agencies, as well as a focused Internet search.

We’ve selected the following materials to get you started:

• Nabilone for the Treatment of Nausea and Vomiting or Anorexia: A Review of Clinical Effectiveness and Guidelines (Summary With Critical Appraisal, February 2019)
• Nabilone for the Treatment of Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness and Guidelines (Summary With Critical Appraisal, February 2019)
• Medical Cannabis (Research Gaps, December 2018)
• Nabilone for Chronic Pain Management: A Review of Clinical Effectiveness and Guidelines – An Update (Summary with Critical Appraisal, November 2018)
• Weeding through the evidence on medical cannabis (Hospital News article, January 2018)